The invention relates to a family of compounds derived from chromenopyrazole of formula (I), which have the capacity to modulate the receptor of the family of the GPR55 canna-binoids, the invention therefore also relating to the use of said compounds for producing a medicament for treating diseases in which the GPR55 receptor has a physiological role, such as diabetes, Parkinsons disease, multiple sclerosis, neuropathic pain, osteoporosis and cancers such as cholangiocarcinoma, breast cancer, ovarian cancer and prostate cancer, glioblas-toma and cutaneous carcinoma. Formula (I)